Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Could China's latest restrictions impact the supply of MRI contrast?
The ongoing trade war between the United States and China could jeopardize the availability of contrast agents used for medical imaging.
Tariffs threaten imaging access for patients, RBMA warns
Radiology practices are already operating on razor thin margins, with price increases prompting calls for congressional action to prevent further damage.
Chinese radiology vendors dodge high tariffs with US-based factories
United Imaging and other manufacturers that have established American factories may remain insulated from the trade war.
SCAI pushes for better radiation protection in cath labs
Society of Cardiovascular Angiography and Interventions President James Hermiller, Jr., MD, explains SCAI's push for wider adoption of new, innovative cath lab radiation protection technology to reduce radiation exposure and the need for lead aprons.
Tariffs will likely have a sizable impact on major radiology vendors
Medical device vendors Siemens, Philips and GE all saw drops in their stock prices after President Donald Trump announced new tariffs April 2.

stroke brain dementia alzheimer's puzzle mental health

AI-based ARIA detection software could bring 'renewed hope' for people undergoing Alzheimer's treatment

The software is the first of its kind to achieve the FDA's approval for detecting, measuring and grading ARIA on MRI scans—a task that is critical in managing the disease.

Video of FDA Commissioner Robert Califf, MD, explaining the need for clinicians to take up fight against health misinformation with grassroots efforts in their communities. #misinformation #FDA #science

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

MRI accident prompts questions on safety

CMS to make proposed MRI safety codes official

The new code family was created to "capture the physician work involving patients with implanted medical devices that require access to MR diagnostic procedures."

Rad's alleged involvement in peddling date rape drug lands him behind bars

Authorities became suspicious of the doctor after intercepting a package containing around 15 pounds of gamma-butyrolactone, a common date rape drug also known as “liquid ecstasy."

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.

Why is the US still dependent on foreign medical isotope production?

The U.S currently does not have any large-scale commercial production of the isotope Mo-99 used for nuclear imaging. It is critical to more 40,000 nuclear imaging exams each day, representing about 80% of all diagnostic molecular imaging procedures.

Medicare coverage expands again for AI-enabled coronary plaque assessments

Another MAC has agreed to cover the use of these advanced technologies to evaluate patients for signs of coronary artery disease.

Around the web

Radiology Business

Tariffs threaten imaging access for patients, RBMA warns

Radiology practices are already operating on razor thin margins, with price increases prompting calls for congressional action to prevent further damage.

Radiology Business

Chinese radiology vendors dodge high tariffs with US-based factories

United Imaging and other manufacturers that have established American factories may remain insulated from the trade war.

Radiology Business

Radiology groups face hardships under the Medicare MIPS program

Erik Rockswold, director research and quality, Rayus Radiology, explains the administrative burdens radiology groups experience for little return from the Merit-Based Incentive Payment System.